Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended		230 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011
Cash flows from operating activities:
Net income (loss)	$ (2,086,853)	$ 1,330,394	$ (196,250,707)
Adjustments to reconcile net loss to net cash used for operating activities:
Purchased in-process research and development			12,146,544
Write-off of acquired technology			3,500,000
Loss on disposition of assets	3,391		3,391
Interest expense settled through issuance of notes payable			350,500
Expenses satisfied with the issuance of stock	28,680		28,680
Forgiveness of debt	(476,837)		(476,837)
Net gain on early extinguishment of debt		(5,277,300)	(5,277,300)
Non-cash gain on restricted stock valuation	(58,814)		(58,814)
Non-cash interest expense		621,406	3,966,394
Non-cash charges related to options, warrants and common stock	834	56,717	11,115,437
Amortization of financing costs	6,948	15,635	25,187
Amortization and depreciation	40,217	44,727	2,890,132
Changes in operating assets and liabilities:
(Increase) decrease in prepaid expenses and other current assets	(32,859)	(47,727)	658,531
(Decrease) increase in accounts payable and accrued expenses	(781,764)	521,701	2,022,380
Increase in accrued interest payable	1,386,239	425,213	6,371,720
Decrease in accrued lease	(96,425)	(36,492)
Net cash used for operating activities	(2,067,243)	(2,345,726)	(158,984,762)
Cash flows from investing activities:
Cash acquired through Merger			1,758,037
Purchases of property and equipment	(2,373)		(1,654,487)
Proceeds from the sale of property and equipment	3,430		3,430
Decrease (increase) in security deposits and other assets	113,657	31,866	(271,241)
Decrease (increase) in indemnity fund	144	122	(115,424)
Purchases of marketable securities			(132,004,923)
Sales and maturities of marketable securities			132,004,923
Net cash provided by (used for) investing activities	114,858	31,988	(279,685)
Cash flows from financing activities:
Proceeds from issuance of common stock			66,731,339
Buyback of common stock			(8,100)
Proceeds from issuance of preferred stock			39,922,170
Preferred stock conversion inducement			(600,564)
Proceeds from issuance of promissory notes	1,940,000	2,735,000	58,185,000
Proceeds from issuance of convertible debentures			9,000,000
Principal payments of notes payable/repurchase of debt		(602,700)	(7,749,667)
Dividend payments on Series E Cumulative Convertible Preferred Stock			(516,747)
Payments of financing costs			(5,612,855)
Net cash provided by financing activities	1,940,000	2,132,300	159,350,576
Net (decrease) increase in cash and cash equivalents	(12,385)	(181,438)	86,129
Cash and cash equivalents, beginning of period	98,514	314,964
Cash and cash equivalents, end of period	86,129	133,526	86,129
Supplemental cash flow disclosures:
Cash paid for interest			628,406
Supplemental disclosure of non-cash financing activity:
Accrued expenses satisfied with the issuance of stock	28,680
Conversion of convertible redeemable preferred stock to common stock	4,600,000
Cumulative accrued interest reversed	640,874
Series F Preferred Stock
Supplemental disclosure of non-cash financing activity:
Number of shares of convertible redeemable preferred stock convertible into common stock	184,000
Conversion of convertible redeemable preferred stock with a total stockholders' equity value	$ 5,240,874